Forschung
Lehre
Lösungen
Anmelden
DE
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Departments of Microbiology & Immunology
Thulasi Warrier has not added Biography.
If you are Thulasi Warrier and would like to personalize this page please email our Author Liaison for assistance.
Old fold in a new X-ray diffraction dataset? Low-resolution molecular replacement using representative structural templates can provide phase information.
Proteins Sep, 2006 | Pubmed ID: 16786600
Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography.
Antimicrobial agents and chemotherapy Nov, 2007 | Pubmed ID: 17846131
X-ray structure of 4,4'-dihydroxybenzophenone mimicking sterol substrate in the active site of sterol 14alpha-demethylase (CYP51).
The Journal of biological chemistry May, 2008 | Pubmed ID: 18367444
Identification of small-molecule scaffolds for p450 inhibitors.
Current protocols in microbiology Feb, 2010 | Pubmed ID: 20131225
Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesis.
Antimicrobial agents and chemotherapy Apr, 2012 | Pubmed ID: 22290959
Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials.
Proceedings of the National Academy of Sciences of the United States of America Oct, 2012 | Pubmed ID: 23012453
N,C-Capped dipeptides with selectivity for mycobacterial proteasome over human proteasomes: role of S3 and S1 binding pockets.
Journal of the American Chemical Society Jul, 2013 | Pubmed ID: 23782398
Benzimidazole-based compounds kill Mycobacterium tuberculosis.
European journal of medicinal chemistry Mar, 2014 | Pubmed ID: 24556148
Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosis.
Journal of medicinal chemistry May, 2014 | Pubmed ID: 24694175
A multi-stress model for high throughput screening against non-replicating Mycobacterium tuberculosis.
Methods in molecular biology (Clifton, N.J.) , 2015 | Pubmed ID: 25779324
Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy Oct, 2015 | Pubmed ID: 26239979
Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis.
Journal of medicinal chemistry Jul, 2016 | Pubmed ID: 27144688
N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis.
Proceedings of the National Academy of Sciences of the United States of America Aug, 2016 | Pubmed ID: 27432954
Identification of Novel Anti-mycobacterial Compounds by Screening a Pharmaceutical Small-Molecule Library against Nonreplicating Mycobacterium tuberculosis.
ACS infectious diseases Dec, 2015 | Pubmed ID: 27623055
Weill Cornell Medical College
Ben Gold1,
Julia Roberts*,1,
Yan Ling*,1,
Landys Lopez Quezada1,
Jou Glasheen1,
Elaine Ballinger1,
Selin Somersan-Karakaya2,
Thulasi Warrier1,
Carl Nathan1
1Departments of Microbiology & Immunology, Weill Cornell Medical College,
2Medicine, Weill Cornell Medical College
Datenschutz
Nutzungsbedingungen
Richtlinien
Kontakt
BIBLIOTHEKS-EMPFEHLUNG
JoVE-Newsletter
JoVE Journal
Methodensammlungen
JoVE Encyclopedia of Experiments
Archiv
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Ressourcen für Lehrende
Autoren
Bibliothekare
Zugang
ÜBER JoVE
Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten